10X GENOMICS INC-CLASS A
TXGNASDAQ🏆 #820 by market capEarnings Nov 4 · PostUS Equity
$90.02▲ $1.52 (+1.69%)
After hours · at closeTrack TXG
Get earnings, price moves & breaking news on Telegram
24h▲ 1.7%
7d▲ 11.5%
14d▲ 21.1%
30d▲ 46.3%
ytd▲ 451.9%
1y▲ 693.8%
🏦Market Cap
$11.43B
Mid Cap
📈Revenue Growth (YoY)
+5.3%
Slowing
📊Gross Margin
70.0%
High
💵FCF Margin
19.7%
Healthy
⚖️P/S Ratio
18.2x
Expensive
Otter Score
72
Fair
10X GENOMICS INC-CLASS A
TXGAnalyst Ratings
Price
$90.02
Total
22
Raised
2
Lowered
3
Avg PT
$67.30
H / L
$110 / $40
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
Piper Sandler | Reiterated | Neutral | 2026-09-28 | $80.00 | −11.10% |
UBS | Reiterated | Neutral | 2026-09-09 | $68.00 | −24.50% |
Stephens & Co. | Reiterated | Overweight | 2026-08-12 | — | — |
Canaccord Genuity | Reiterated | Buy | 2026-08-10 | $60.00 | −33.30% |
Morgan Stanley | Reiterated | Equal Weight | 2026-08-07 | $40.00 | −55.60% |
Citigroup | Reiterated | Neutral | 2026-08-07 | — | — |
Leerink Partners | Reiterated | Market Perform | 2026-07-17 | $90.00 | +0.00% |
Barclays | Reiterated | Overweight | 2026-06-24 | $40.00 | −55.60% |
JP Morgan | Reiterated | Neutral | 2026-05-12 | — | — |
B of A Securities | Reiterated | Neutral | 2026-04-20 | — | — |
William Blair | Upgraded | Market Perform → Outperform | 2026-03-31 | — | — |
Stifel | Reiterated | Buy | 2026-03-02 | — | — |
TD Cowen | Reiterated | Hold | 2026-02-13 | — | — |
Goldman Sachs | Reiterated | Sell | 2025-05-12 | — | — |
Jefferies | Upgraded | Hold → Buy | 2024-07-22 | $24.00 | −73.30% |
Deutsche Bank | Downgraded | Buy → Hold | 2024-07-10 | $17.00 | −81.10% |
Wolfe Research | Downgraded | Outperform → Peer Perform | 2024-06-27 | — | — |
Guggenheim | Downgraded | Buy → Neutral | 2024-06-26 | — | — |
Cowen & Co. | Reiterated | Outperform | 2023-02-16 | — | — |
Guggenheim Securities | Reiterated | Buy | 2020-03-05 | — | — |
Bank of America | Reiterated | Buy | 2019-10-07 | — | — |
Evercore ISI Group | Reiterated | Outperform | 2019-09-24 | — | — |
Institution
Piper Sandler
Reiterated · Neutral · 2026-09-28
$80.00
−11.10%
UBS
Reiterated · Neutral · 2026-09-09
$68.00
−24.50%
Stephens & Co.
Reiterated · Overweight · 2026-08-12
—
—
Canaccord Genuity
Reiterated · Buy · 2026-08-10
$60.00
−33.30%
Morgan Stanley
Reiterated · Equal Weight · 2026-08-07
$40.00
−55.60%
Citigroup
Reiterated · Neutral · 2026-08-07
—
—
Leerink Partners
Reiterated · Market Perform · 2026-07-17
$90.00
+0.00%
Barclays
Reiterated · Overweight · 2026-06-24
$40.00
−55.60%
JP Morgan
Reiterated · Neutral · 2026-05-12
—
—
B of A Securities
Reiterated · Neutral · 2026-04-20
—
—
William Blair
Upgraded · Market Perform → Outperform · 2026-03-31
—
—
Stifel
Reiterated · Buy · 2026-03-02
—
—
TD Cowen
Reiterated · Hold · 2026-02-13
—
—
Goldman Sachs
Reiterated · Sell · 2025-05-12
—
—
Jefferies
Upgraded · Hold → Buy · 2024-07-22
$24.00
−73.30%
Deutsche Bank
Downgraded · Buy → Hold · 2024-07-10
$17.00
−81.10%
Wolfe Research
Downgraded · Outperform → Peer Perform · 2024-06-27
—
—
Guggenheim
Downgraded · Buy → Neutral · 2024-06-26
—
—
Cowen & Co.
Reiterated · Outperform · 2023-02-16
—
—
Guggenheim Securities
Reiterated · Buy · 2020-03-05
—
—
Bank of America
Reiterated · Buy · 2019-10-07
—
—
Evercore ISI Group
Reiterated · Outperform · 2019-09-24
—
—
One row per institution · price target from the firm's latest published target
StockOtter · stockotter.space